Cancer vaccine may be available by 2030
The co-founders of the biotechnology company BioNTech announced the creation of a personalized cancer vaccine by 2030. Breakthroughs in mRNA vaccines from COVID-19, achieved during the pandemic, helped speed up the process. Professors Ugur Şahin and Özlem Turecı, founders of the biotechnology company BioNTech in Germany, told the BBC. BioNTech, in partnership with Pfizer, was…